KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2023.216598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Meihua Shan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Army Medical University, Chongqing, 400038, China. Hauptthemen laut MEDLINE: Adenine, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
N6-methyladenosine (m6A), a dynamically reversible modification in eukaryotic RNAs, modulates gene expression and pathological processes in various tumors. KIAA1429, the largest component of the m6A methyltransferase complex, plays an important role in m6A modification. However, the underlying mechanism of KIAA1429 in hepatocellular carcinoma (HCC) remains largely unknown. Immunohistochemical assay was performed to examine the expression of KIAA1429 in HCC tissues. Transwell, wound healing and animal experiments were used to investigate the influence of KIAA1429 on cell migration and invasion. The mRNA high-throughput sequencing (RNA-seq) and methylated RNA immunoprecipitation sequencing (MeRIP-seq) were performed to screen the downstream target of KIAA1429. RNA stability assays, RNA immunoprecipitation assay (RIP), MeRIP-qPCR and luciferase assay were used to evaluate the relationship between KIAA1429 and the m6A-modified genes. Results showed that the expression level of KIAA1429 was significantly higher in HCC tissues than in adjacent tissues, and the upregulation of KIAA1429 could promote HCC metastasis in vitro and in vivo. Mechanistically, we confirmed that KIAA1429 negatively regulated the tumor suppressor, Rho family GTPase 3 (RND3), by decreasing its mRNA stability in coordination with the m6A reader YTHDC1. Moreover, we demonstrated that KIAA1429 could regulate the m6A modification of RND3 mRNA via its RNA binding domain. Our data indicated that KIAA1429 exerted its oncogenic role by inhibiting RND3 expression in an m6A-dependent manner, suggesting that KIAA1429 might be a potential prognostic biomarker and therapeutic target in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Army Medical University, Chongqing, 400038, China.
- Department of Biochemistry and Molecular Biology, Army Medical University, Chongqing, 400038, China.
- Department of Biochemistry and Molecular Biology, Army Medical University, Chongqing, 400038, China. Electronic address: hefengtian66@aliyun.com.
- School of Medicine, Nankai University, Tianjin, 300071, China. Electronic address: wangyue@nankai.edu.cn.
- Department of Clinical Biochemistry, Army Medical University, Chongqing, 400038, China. Electronic address: lianjiqin@sina.com.
Förderung
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Shan, M., Liu, D., Sun, L., Yang, M., He, M., Zhang, Y., Xiang, L., Lu, L., He, H., Niu, D., Chen, L., Li, S., Chen, A., He, F., Wang, Y., & Lian, J. (2024). KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216598
Vancouver
Shan M, Liu D, Sun L, Yang M, He M, Zhang Y, et al. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. Cancer Letters. 2024. doi:10.1016/j.canlet.2023.216598
BibTeX
@article{Shan2024,
author = {Shan, Meihua and Liu, Dong and Sun, Liangbo and Yang, Mingzhen and He, Meng and Zhang, Yang and Xiang, Li and Lu, Lu and He, Haiyan and Niu, Dun and Chen, Lingxi and Li, Shuhui and Chen, An and He, Fengtian and Wang, Yue and Lian, Jiqin},
title = {KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2023.216598}
}
EUVIMED